Results 81 to 90 of about 932 (190)

[Biochemical mechanisms of mildronate action during ischemic stress].

open access: yesLikars'ka sprava, 2004
The authors in the article described biochemical mechanisms of Mildronat. The main mechanism of Mildronat activity is based on decreasing carnitine level in the organism, which leads to hampering oxidation of fatty acids. Mildronat is believed keeps on training myocardium pharmacologically even without physical activity by adapting cells to decreasing ...
M, Dambrova   +4 more
openaire   +1 more source

ENDOTHELIAL DYSFUNCTION AND ITS CORRECTION WIT CYTOPROTECTORS IN PATIENTS WITH STABLE EFFORT ANGINA AND ARTERIAL HYPERTENSION

open access: yesРоссийский кардиологический журнал, 2009
The study compared the effects of cardiocytoprotectors (mildronate, trimetazidine) on endothelial function, physical stress tolerability, and circadian blood pressure (BP) profile in patients with arterial hypertension (AH; n=60) and stable angina (n=82),
F. E. Khlebodarov   +2 more
doaj  

Кардиоцитопротекторы — новое направление клинической кардиологии

open access: yesАрхивъ внутренней медицины, 2011
Treatment and secondary prevention of cardiovascular diseases, which are based on coronary heart disease and hypertension, remains one of the most urgent problems of modern cardiology.
В. П. Мухин
doaj   +1 more source

State stiffness parameters of the vascular wall in hypertensive patients complex therapy cytoprotector and sartans

open access: yesАрхивъ внутренней медицины, 2015
A randomized study of the state of stiffness parameters arteries wall (CAVI — cardio-ankle vascular index), AI (augmentation index) PEP (duration of the voltage of the left ventricle) using «VaSera-1000» («Fukuda Denshi», Japan) in primary hypertension ...
V. P. Mikhin   +3 more
doaj   +1 more source

New views of mildronate use for the prevention and correction of impairment of adaptive processes

open access: yesRUDN Journal of Medicine, 2010
Protective and normalizing mildronate action on the level of non enzyme kation proteins in the neurophils and contents of kateholamins in erythrocytes were revealed on the experimental model of the emotional-pain stress.
L V Logunova
doaj  

Experience with mildronate in cerebrovascular diseases

open access: yesМедицинский совет, 2015
Over the past years, results of various clinical trials of drugs demonstrating their efficacy in the treatment of cardiovascular diseases have been published. The article discusses the results of clinical use of Mildronate (meldonium) in the treatment of ischemic brain injuries; the results of trials show that the medicine has a cytoprotective effect ...
openaire   +1 more source

Synthesis and biocompatibility study of ceria-mildronate nanocomposite in vitro [PDF]

open access: yesNanosystems: Physics, Chemistry, Mathematics, 2022
A.L. Popov   +9 more
openaire   +1 more source

THE EFFECT OF A CAVERGAL ON THE PARAMETERS OF CARBOHYDRATE AND LIPID METABOLISM IN RABBITS WITH METABOLIC SYNDROME. [PDF]

open access: yes, 2018
Objective: of the study was to study the effect of kavergal on the parameters of carbohydrate and lipid metabolism in rabbits with a metabolic syndrome. Material and methods. Experiments were performed on 18 rabbits.
Inoyatova, F.H., Khidoyatova, M.R
core   +1 more source

PHARMACEUTICAL CORRECTION OF VASCULAR DISTURBANCES IN PATIENTS WITH ARTERIAL HYPERTENSION

open access: yesРоссийский кардиологический журнал, 2010
Aim: To study vascular stiffness and elasticity, microcirculation (MC) parameters, and mildronate effects in patients with arterial hypertension (AH). Material and methods.
L. A. Khaisheva   +4 more
doaj  

ANTI-INFLAMMATORY, ANTIHYPOXANT AND ANTIOXIDANT ACTIVITY OF PRODUCTS ISOLATED FROM CAPER CULTIVATED IN UZBEKISTAN [PDF]

open access: yes
Caper extracts have been reported to possess antibacterial, antifungal, analgesic, antitumor, hepatoprotective, antioxidant, anti-inflammatory, and neuroprotective effects.
Aytbaeva Aygul Baxtiyarovna   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy